-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Marsh & McLennan posted Q1 2026 adjusted EPS of $3.29 vs. $3.06 in the prior year, beating our $3.26 estimate and the $3.22 consensus view. Q1 revenue rose 8%, but underlying growth of 4% lagged peers, reflecting 3% currency boost and 1% acquisition contribution masking mixed organic trends across the Risk & Insurance Services and Consulting units. We remain concerned consulting demand could face headwinds from AI-driven shifts in business spending, though we expect its acquisition strategy to remain intact over the long term. The company rebranded as Marsh (ticker: MRSH) and formed a Business and Client Services unit to boost operational efficiency. Given Q1 operating margin contraction to 23.1% from 28.4%, we expect restructuring actions as the firm integrates recent deals and leverages technology improvements. We anticipate a near-term acquisition pause as the firm digests transactions amid macroeconomic uncertainty, though its margins historically lag peers despite a premium valuation to its peer group.